Millipore Sigma Vibrant Logo

AB15558-200UL Anti-Somatostatin Receptor Type 2 Antibody

Anti-Somatostatin Receptor Type 2 Antibody is an antibody against Somatostatin Receptor Type 2 for use in IH & WB.

Anti-Somatostatin Receptor Type 2 Antibody MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Neuroscience Research Sub-Category: CNS Control of Metabolism, Hormones & Receptors Gene Symbol: DLG3, Neuroendocrine-DLG, KIAA1232, MRX90, SAP102, MRX, NE-dlg, NE-Dlg, XLMR, neuroendocrine-dlg, NEDLG UniProt Number: Q92796
AB15558-200UL
200 µL  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Special Offers

      100% Performance Guaranteed

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      M, RIHC, WBRbPurifiedPolyclonal Antibody
      Description
      Catalogue NumberAB15558-200UL
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Somatostatin Receptor Type 2 Antibody
      Alternate Names
      • SSTR2
      References
      Product Information
      FormatPurified
      Control
      • Included free of charge with the antibody is 40 µg of control antigen (lyophilized powder). The stock solution of the antigen can be made up using 100 µL of sterile deionized water. For negative control, preincubate 1 µg of peptide with 1 µg of antibody for one hour at room temperature. Optimal concentrations must be determined by the end user.
      PresentationLyophilized from phosphate buffered saline, pH 7.4, containing 1% BSA, and 0.05% sodium azide as a preservative. Reconstitute with 200 μL of sterile deionized water. Centrifuge antibody preparation before use (10,000 xg for 5 min).
      Quality LevelMQ100
      Applications
      ApplicationAnti-Somatostatin Receptor Type 2 Antibody is an antibody against Somatostatin Receptor Type 2 for use in IH & WB.
      Key Applications
      • Immunohistochemistry
      • Western Blotting
      Application NotesWestern blot: 1:200-1:500 using ECL on rat brain and pancreas lysate.
      Dilutions should be made using a carrier protein such as BSA (1-3%).

      Optimal working dilutions must be determined by the end user.
      Biological Information
      ImmunogenPurified peptide from the N-terminus of rat Somatostatin Receptor Type 2 (Accession number P30680).
      HostRabbit
      SpecificityRecognizes Somatostatin Receptor Type 2 (SSTR2).
      Species Reactivity
      • Mouse
      • Rat
      Species Reactivity NoteThe immunogen sequence is 12 of 15 amino acids identical in human and porcine.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • DLG3
      • Neuroendocrine-DLG
      • KIAA1232
      • MRX90
      • SAP102
      • MRX
      • NE-dlg
      • NE-Dlg
      • XLMR
      • neuroendocrine-dlg
      • NEDLG
      Purification MethodImmunoAffinity Purified
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: Q92796 # Required for learning most likely through its role in synaptic plasticity following NMDA receptor signaling.
      SIZE: 817 amino acids; 90344 Da
      SUBUNIT: Interacts through its PDZ domains with GRIN2B and SYNGAP1. Interacts through its guanylate kinase-like domain with DLGAP1, DLGAP2, DLGAP3 and DLGAP4 (By similarity). Interacts through its PDZ domains with APC. Interacts through its first two PDZ domains with ERBB4. Interacts through its third PDZ domain with NLGN1, and probably with NLGN2 and NLGN3.
      DISEASE: SwissProt: Q92796 # Defects in DLG3 are the cause of non-syndromic mental retardation X-linked type 90 (MRX90) [MIM:300189]. Mental retardation is characterized by significantly sub-average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. Non- syndromic mental retardation patients do not manifest other clinical signs.
      SIMILARITY: SwissProt: Q92796 ## Belongs to the MAGUK family. & Contains 1 guanylate kinase-like domain. & Contains 3 PDZ (DHR) domains. & Contains 1 SH3 domain.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain lyophilized material at -20°C for up to 12 months after date of receipt. After reconstitution maintain at -20°C in undiluted aliquots for up to 6 months. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size200 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      AB15558-200UL 04053252271632

      Related Products & Applications

      Related Products

      Catalogue Number Description  
      AB15558-50UL Anti-Somatostatin Receptor Type 2 Antibody Show Pricing & Availability

      Alternative Packsize

      Catalogue Number Description  
      AB15558-50UL Anti-Somatostatin Receptor Type 2 Antibody Show Pricing & Availability

      Categories

      Life Science Research > Antibodies and Assays > Primary Antibodies